TY - JOUR
T1 - Multiple sclerosis
T2 - Current pathophysiological concepts
AU - Wingerchuk, Dean M.
AU - Lucchinetti, Claudia F.
AU - Noseworthy, John H.
N1 - Copyright:
Copyright 2017 Elsevier B.V., All rights reserved.
PY - 2001
Y1 - 2001
N2 - Multiple sclerosis (MS) is an often disabling disease primarily affecting young adults that exhibits extraordinary clinical, radiological, and pathological heterogeneity. We review the following: (a) known environmental and genetic factors that contribute to MS susceptibility; (b) current knowledge regarding fundamental pathophysiological processes in MS, including immune cell recruitment and entry into the central nervous system (CNS), formation of the plaque, and orchestration of the immune response; (c) descriptive and qualitative distinct pathological patterns in MS and their implications; (d) the evidence supporting the causative role of direct toxins, cell-mediated and humorally mediated immune mechanisms, and the concept of a "primary oligodendrogliopathy" in demyelination and axonal injury; (e) the potential benefits of inflammation; (f) the prospects for remyelination; and (g) therapeutic implications and approaches suggested by putative pathophysiological mechanisms.
AB - Multiple sclerosis (MS) is an often disabling disease primarily affecting young adults that exhibits extraordinary clinical, radiological, and pathological heterogeneity. We review the following: (a) known environmental and genetic factors that contribute to MS susceptibility; (b) current knowledge regarding fundamental pathophysiological processes in MS, including immune cell recruitment and entry into the central nervous system (CNS), formation of the plaque, and orchestration of the immune response; (c) descriptive and qualitative distinct pathological patterns in MS and their implications; (d) the evidence supporting the causative role of direct toxins, cell-mediated and humorally mediated immune mechanisms, and the concept of a "primary oligodendrogliopathy" in demyelination and axonal injury; (e) the potential benefits of inflammation; (f) the prospects for remyelination; and (g) therapeutic implications and approaches suggested by putative pathophysiological mechanisms.
UR - http://www.scopus.com/inward/record.url?scp=0035076486&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0035076486&partnerID=8YFLogxK
U2 - 10.1038/labinvest.3780235
DO - 10.1038/labinvest.3780235
M3 - Review article
C2 - 11310820
AN - SCOPUS:0035076486
SN - 0023-6837
VL - 81
SP - 263
EP - 281
JO - Laboratory Investigation
JF - Laboratory Investigation
IS - 3
ER -